BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Adhoute X, Pénaranda G, Raoul JL, Bourlière M. Usefulness of the MESH score in a European hepatocellular carcinoma cohort. World J Hepatol 2017; 9(15): 711-714 [PMID: 28596819 DOI: 10.4254/wjh.v9.i15.711]
URL: https://www.wjgnet.com/1948-5182/full/v9/i15/711.htm
Number Citing Articles
1
Xavier Adhoute, Guillaume Penaranda, Jean Luc Raoul, Marc Bourlière. Intermediate stage treatment: Is TACE enough?Liver International 2018; 38(1): 187 doi: 10.1111/liv.13598
2
Sophia Heinrich, Martin Sprinzl, Irene Schmidtmann, Elena Heil, Sandra Koch, Carolin Czauderna, Bernd Heinrich, Laurence Philippe P Diggs, Marcus‐Alexander Wörns, Roman Kloeckner, Peter R Galle, Jens U Marquardt, Arndt Weinmann. Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patientsUnited European Gastroenterology Journal 2020; 8(4): 444 doi: 10.1177/2050640620904524
3
Giovanni Marasco, Franco Trevisani. Time to move beyond the classical prognostic systems for patients with advanced hepatocellular carcinoma undergoing SorafenibDigestive and Liver Disease 2021; 53(9): 1210 doi: 10.1016/j.dld.2021.04.037
4
Moritz Gross, Stefan P. Haider, Tal Ze’evi, Steffen Huber, Sandeep Arora, Ahmet S. Kucukkaya, Simon Iseke, Bernhard Gebauer, Florian Fleckenstein, Marc Dewey, Ariel Jaffe, Mario Strazzabosco, Julius Chapiro, John A. Onofrey. Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learningEuropean Radiology 2024; 34(10): 6940 doi: 10.1007/s00330-024-10624-8
5
Xavier Adhoute, Guillaume Penaranda, Jean‐Luc Raoul, Marc Bourlière. Prediction of benefit after transarterial chemoembolization (TACE): Subclassifications or scoring systems?Liver International 2018; 38(1): 184 doi: 10.1111/liv.13516